Unravel Biosciences
Startup
Unravel Biosciences is a clinical-stage therapeutics company that combines AI-driven systems biology with rapid clinical validation of newly discovered targets. Unravel leverages its proprietary BioNAV™ platform and primary transcriptomic data to create Living Molecular Twins of real patients that can be used to predict therapeutic response. This Predictable Medicine™ approach enables systematic, data-driven target and drug discovery, preclinical screening, patient stratification, and clinical validation to find treatments for complex diseases. Our rareSHIFT™ program extends this platform and proprietary Datamine to foundation and biotech partners, helping them accelerate and clinically derisk their therapeutics.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events